Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Recruiting 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 6Tumor-Agnostic 4Genitourinary 4CNS 3Lymphoid 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1Gynecologic 1Dermatologic 1

Conditions

Lung Neoplasms 6Smoking Cessation 2Solitary Pulmonary Nodule 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Pancreatic cancer, adult 1Ovarian Neoplasms 1Neoplasms 1Motor Activity 1Inflammation 1Glioblastoma 1Disease 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Hematologic Tests × Thoracic × 1 year × Clear all
NCT07623473 2026-06-03

NIMBLE

Herlev and Gentofte Hospital

Recruiting
1,800 enrolled
Thoracic

Solitary Pulmonary Nodule, Disease, Lung Neoplasms

NCT01687647 2026-05-29

AMORCE-CBP

University Hospital, Caen

Phase 3 Terminated
463 enrolled
Thoracic

Lung Neoplasms

NCT06620835 2026-04-29

OPTALK

Groupe Francais De Pneumo-Cancerologie

Phase 2 Recruiting
45 enrolled
Thoracic

Lung Neoplasms

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
7,324 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT06717295 2026-01-02

CCANED-CIPHER

Dysplasia Diagnostics Limited

Recruiting
6,000 enrolled
CNSGastrointestinalGenitourinaryGynecologicThoracic

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡